MIG Capital

Founded in Munich, Germany in 2004, MIG Capital is a leading venture capital firm focusing on European Deep Tech and Life Sciences investments from seed to late-stage. With over €1.2 billion committed by private investors across Germany and Austria, the firm manages 17 public venture capital funds regulated by BaFin.

Klaus Feix Ph.D

Venture Partner

Andreas Kastenbauer

Venture Partner

Jürgen Kosch

Co-Founder and Managing Partner

Axel Thierauf

Venture Partner

Fei Tian Ph.D

Principal

Past deals in Central Europe

CoreMedic

Series B in 2025
CoreMedic develops innovative devices for treating heart valve diseases. Its flagship product is ChordArt, a minimally invasive mitral valve repair system that addresses regurgitation by replacing or reinforcing chordae tendineae via a trans-femoral approach at the beating heart.

AMSilk

Series C in 2023
AMSilk GmbH is a Munich-based company that specializes in the production of spider silk proteins and other biomaterials for a variety of industrial applications. Founded in 2008, AMSilk manufactures high-quality silk biopolymers that serve diverse sectors, including pharmaceuticals, cosmetics, and technical textiles. Its product offerings include BioShield-S1, a non-immunogenic spider silk film for protective coatings, as well as biosteel spider silk fibers. The company also develops a range of wound care products and surgical applications, such as the SanaSilk durable skin barrier. Additionally, AMSilk provides spider silk protein beads and coatings for medical technology, alongside nonwovens for filters, wound dressings, and specialty textiles. Utilizing a patented biotechnological process, AMSilk's materials are fully biodegradable under aerobic and marine conditions, promoting sustainability in various applications. The company collaborates with partners like Gruschwitz Textilwerke AG to enhance its product offerings.

KEWAZO

Series A in 2023
KEWAZO develops autonomous robotics systems for construction sites. Its primary product is LIFTBOT, a robotic material hoist that safely transports scaffolding parts during assembly, reducing labor costs by up to 44%, addressing labor shortages, and enhancing safety. Additionally, Kewazo collects operational data from its robots on-site, providing customers with a data analytics platform for proactive project management.

NavVis

Venture Round in 2021
NavVis develops indoor spatial intelligence solutions, enabling enterprises to capture and share built environments as photorealistic digital twins. Its SLAM-based mobile mapping systems generate high-quality data with survey-grade accuracy, facilitating better operational decisions and improved productivity.

Efficient Energy

Series A in 2021
Efficient Energy GmbH, based in Feldkirchen near Munich, Germany, specializes in the development, manufacturing, and distribution of environmentally friendly refrigeration systems for both industrial and home applications. Established in 2006, the company is recognized for its innovative eChiller, which utilizes pure water as a refrigerant, effectively avoiding the use of harmful fluorinated gases. This technology addresses regulatory challenges in refrigeration while providing efficient cooling solutions for data centers, server rooms, and various industrial processes. The eChiller models offer cooling capacities ranging from 35 kW to 120 kW and are designed to deliver cost efficiency and a low carbon footprint. Efficient Energy also provides a range of services, including consulting, planning, installation, and maintenance, ensuring optimal energy efficiency for its clients. The company's pioneering work has garnered multiple awards, highlighting its commitment to sustainable practices in refrigeration technology.

iOmx Therapeutics

Series B in 2021
iOmx Therapeutics AG is a Munich-based company specializing in immuno-oncology target discovery and drug development. The company focuses on creating first-in-class cancer therapeutics that target novel immune checkpoint modulators present on tumor cells. Utilizing a proprietary siRNA-based screening technology, iOmx systematically analyzes human tumor cells to identify innovative therapeutic targets and understand their mechanisms of action. The company's approach is rooted in the principles of cancer immune-checkpoint therapy, which aims to overcome tumors' inherent resistance to immune attacks. This resistance is often mediated by cell surface molecules that inhibit T cell activation. By neutralizing these negative interactions, iOmx Therapeutics seeks to reactivate the host immune response, ultimately enhancing the effectiveness of cancer treatments.

KEWAZO

Series A in 2021
KEWAZO develops autonomous robotics systems for construction sites. Its primary product is LIFTBOT, a robotic material hoist that safely transports scaffolding parts during assembly, reducing labor costs by up to 44%, addressing labor shortages, and enhancing safety. Additionally, Kewazo collects operational data from its robots on-site, providing customers with a data analytics platform for proactive project management.

AMSilk

Series C in 2021
AMSilk GmbH is a Munich-based company that specializes in the production of spider silk proteins and other biomaterials for a variety of industrial applications. Founded in 2008, AMSilk manufactures high-quality silk biopolymers that serve diverse sectors, including pharmaceuticals, cosmetics, and technical textiles. Its product offerings include BioShield-S1, a non-immunogenic spider silk film for protective coatings, as well as biosteel spider silk fibers. The company also develops a range of wound care products and surgical applications, such as the SanaSilk durable skin barrier. Additionally, AMSilk provides spider silk protein beads and coatings for medical technology, alongside nonwovens for filters, wound dressings, and specialty textiles. Utilizing a patented biotechnological process, AMSilk's materials are fully biodegradable under aerobic and marine conditions, promoting sustainability in various applications. The company collaborates with partners like Gruschwitz Textilwerke AG to enhance its product offerings.

Efficient Energy

Venture Round in 2020
Efficient Energy GmbH, based in Feldkirchen near Munich, Germany, specializes in the development, manufacturing, and distribution of environmentally friendly refrigeration systems for both industrial and home applications. Established in 2006, the company is recognized for its innovative eChiller, which utilizes pure water as a refrigerant, effectively avoiding the use of harmful fluorinated gases. This technology addresses regulatory challenges in refrigeration while providing efficient cooling solutions for data centers, server rooms, and various industrial processes. The eChiller models offer cooling capacities ranging from 35 kW to 120 kW and are designed to deliver cost efficiency and a low carbon footprint. Efficient Energy also provides a range of services, including consulting, planning, installation, and maintenance, ensuring optimal energy efficiency for its clients. The company's pioneering work has garnered multiple awards, highlighting its commitment to sustainable practices in refrigeration technology.

KEWAZO

Seed Round in 2020
KEWAZO develops autonomous robotics systems for construction sites. Its primary product is LIFTBOT, a robotic material hoist that safely transports scaffolding parts during assembly, reducing labor costs by up to 44%, addressing labor shortages, and enhancing safety. Additionally, Kewazo collects operational data from its robots on-site, providing customers with a data analytics platform for proactive project management.

Biocrates Life Sciences

Venture Round in 2019
Biocrates Life Sciences AG is a biotechnology company based in Innsbruck, Austria, specializing in targeted metabolic phenotyping solutions. Founded in 2002, the company develops and markets mass-spectrometry based kits and services that facilitate the analysis of endogenous metabolites. These tools are essential for discovering and validating biomarkers associated with complex multifactorial diseases, including cancer and neurodegenerative disorders. Biocrates provides a comprehensive metabolomics platform that integrates automated sample preparation workflows with advanced mass-spectrometric techniques, enabling rapid and reliable identification of hundreds of metabolites. Their products and services cater to a wide range of research areas, such as cardiovascular health, diabetes, endocrinology, pharmacology, and more. Biocrates Life Sciences distributes its solutions through authorized partners across various regions, including the Middle East, Europe, and parts of Asia.

Efficient Energy

Venture Round in 2019
Efficient Energy GmbH, based in Feldkirchen near Munich, Germany, specializes in the development, manufacturing, and distribution of environmentally friendly refrigeration systems for both industrial and home applications. Established in 2006, the company is recognized for its innovative eChiller, which utilizes pure water as a refrigerant, effectively avoiding the use of harmful fluorinated gases. This technology addresses regulatory challenges in refrigeration while providing efficient cooling solutions for data centers, server rooms, and various industrial processes. The eChiller models offer cooling capacities ranging from 35 kW to 120 kW and are designed to deliver cost efficiency and a low carbon footprint. Efficient Energy also provides a range of services, including consulting, planning, installation, and maintenance, ensuring optimal energy efficiency for its clients. The company's pioneering work has garnered multiple awards, highlighting its commitment to sustainable practices in refrigeration technology.

NavVis

Series C in 2018
NavVis develops indoor spatial intelligence solutions, enabling enterprises to capture and share built environments as photorealistic digital twins. Its SLAM-based mobile mapping systems generate high-quality data with survey-grade accuracy, facilitating better operational decisions and improved productivity.

Efficient Energy

Venture Round in 2018
Efficient Energy GmbH, based in Feldkirchen near Munich, Germany, specializes in the development, manufacturing, and distribution of environmentally friendly refrigeration systems for both industrial and home applications. Established in 2006, the company is recognized for its innovative eChiller, which utilizes pure water as a refrigerant, effectively avoiding the use of harmful fluorinated gases. This technology addresses regulatory challenges in refrigeration while providing efficient cooling solutions for data centers, server rooms, and various industrial processes. The eChiller models offer cooling capacities ranging from 35 kW to 120 kW and are designed to deliver cost efficiency and a low carbon footprint. Efficient Energy also provides a range of services, including consulting, planning, installation, and maintenance, ensuring optimal energy efficiency for its clients. The company's pioneering work has garnered multiple awards, highlighting its commitment to sustainable practices in refrigeration technology.

KEWAZO

Seed Round in 2018
KEWAZO develops autonomous robotics systems for construction sites. Its primary product is LIFTBOT, a robotic material hoist that safely transports scaffolding parts during assembly, reducing labor costs by up to 44%, addressing labor shortages, and enhancing safety. Additionally, Kewazo collects operational data from its robots on-site, providing customers with a data analytics platform for proactive project management.

BioNTech

Series A in 2018
BioNTech is a Germany-based biotechnology company focused on developing cancer therapeutics and vaccines for infectious diseases. Its portfolio includes mRNA-based therapies to encode antigens and neoantigens, cytokines, and antibodies; cell therapies; bispecific antibodies; and antibody-drug conjugates. The company maintains an oncology pipeline and collaborates on vaccines for infectious diseases, including a COVID-19 vaccine developed with Pfizer.

Siltectra

Series B in 2017
SILTECTRA GmbH, founded in 2010 and based in Dresden, Germany, specializes in advanced laser-based wafering technology for semiconductor manufacturers. The company has developed innovative kerfless wafering and thinning solutions that enable the separation of wafers from semiconductor materials, such as silicon carbide, gallium nitride, and sapphire, without material loss. This technology is particularly beneficial for applications in solar inverters and various electronic devices, providing significant performance and cost advantages to the global semiconductor industry. SILTECTRA operates as a subsidiary of Infineon Technologies AG and aims to enhance manufacturing processes across multiple industries through its cutting-edge solutions.

Hemovent

Series A in 2017
Hemovent is a medical technology company based in Aachen, Germany, focused on developing a portable ECMO (Extra Corporeal Membrane Oxygenation) unit. Founded by Christof Lenz and Oliver Marseille, the company aims to create an innovative device that supports or replaces heart and lung functions during cardiac or respiratory failure. Hemovent's device is designed to provide respiratory support for patients with severely damaged lungs and serves as a temporary life support system, taking over heart function in cases of acute heart failure. This technology enables hospitals to stabilize patients and address underlying health issues effectively, while also allowing for increased patient mobility during treatment.

Efficient Energy

Venture Round in 2017
Efficient Energy GmbH, based in Feldkirchen near Munich, Germany, specializes in the development, manufacturing, and distribution of environmentally friendly refrigeration systems for both industrial and home applications. Established in 2006, the company is recognized for its innovative eChiller, which utilizes pure water as a refrigerant, effectively avoiding the use of harmful fluorinated gases. This technology addresses regulatory challenges in refrigeration while providing efficient cooling solutions for data centers, server rooms, and various industrial processes. The eChiller models offer cooling capacities ranging from 35 kW to 120 kW and are designed to deliver cost efficiency and a low carbon footprint. Efficient Energy also provides a range of services, including consulting, planning, installation, and maintenance, ensuring optimal energy efficiency for its clients. The company's pioneering work has garnered multiple awards, highlighting its commitment to sustainable practices in refrigeration technology.

AFFiRiS

Venture Round in 2017
AFFiRiS AG is a biotechnology company based in Vienna, Austria, specializing in the development and manufacture of peptide-based vaccines aimed at the therapeutic treatment of chronic diseases with significant unmet medical needs. Founded in 2003, the company focuses on creating tailored vaccines for a range of conditions, including Alzheimer’s disease, Parkinson’s disease, atherosclerosis, hypertension, diabetes, psoriasis, allergies, asthma, and Huntington’s disease, among others. Through its innovative approach, AFFiRiS seeks to address critical health challenges and improve patient outcomes in various therapeutic areas.

LXP Group

Series A in 2017
LXP Group develops LX-Process, an energy processing technology that treats 2G biomass to enable production of bio-based fuels and chemicals. The process converts biomass into the main components cellulose, hemicellulose, and lignin, and can be applied to convert leftover agricultural residues into bio-based chemicals and fuels. LX-Process can be scaled for large 2G ethanol manufacturing while also enabling economic retrofitting of smaller, decentralized biogas plants, and it addresses inhibitors formed during pre-treatment that hinder other methods. The company provides a pathway from agricultural waste to sustainable fuels and chemicals, supporting decarbonization goals. LXP Group is based in Marienwerder, Germany, and has been active since 2009.

Siltectra

Series B in 2017
SILTECTRA GmbH, founded in 2010 and based in Dresden, Germany, specializes in advanced laser-based wafering technology for semiconductor manufacturers. The company has developed innovative kerfless wafering and thinning solutions that enable the separation of wafers from semiconductor materials, such as silicon carbide, gallium nitride, and sapphire, without material loss. This technology is particularly beneficial for applications in solar inverters and various electronic devices, providing significant performance and cost advantages to the global semiconductor industry. SILTECTRA operates as a subsidiary of Infineon Technologies AG and aims to enhance manufacturing processes across multiple industries through its cutting-edge solutions.

AFFiRiS

Venture Round in 2016
AFFiRiS AG is a biotechnology company based in Vienna, Austria, specializing in the development and manufacture of peptide-based vaccines aimed at the therapeutic treatment of chronic diseases with significant unmet medical needs. Founded in 2003, the company focuses on creating tailored vaccines for a range of conditions, including Alzheimer’s disease, Parkinson’s disease, atherosclerosis, hypertension, diabetes, psoriasis, allergies, asthma, and Huntington’s disease, among others. Through its innovative approach, AFFiRiS seeks to address critical health challenges and improve patient outcomes in various therapeutic areas.

Siltectra

Series B in 2016
SILTECTRA GmbH, founded in 2010 and based in Dresden, Germany, specializes in advanced laser-based wafering technology for semiconductor manufacturers. The company has developed innovative kerfless wafering and thinning solutions that enable the separation of wafers from semiconductor materials, such as silicon carbide, gallium nitride, and sapphire, without material loss. This technology is particularly beneficial for applications in solar inverters and various electronic devices, providing significant performance and cost advantages to the global semiconductor industry. SILTECTRA operates as a subsidiary of Infineon Technologies AG and aims to enhance manufacturing processes across multiple industries through its cutting-edge solutions.

Hemovent

Series A in 2016
Hemovent is a medical technology company based in Aachen, Germany, focused on developing a portable ECMO (Extra Corporeal Membrane Oxygenation) unit. Founded by Christof Lenz and Oliver Marseille, the company aims to create an innovative device that supports or replaces heart and lung functions during cardiac or respiratory failure. Hemovent's device is designed to provide respiratory support for patients with severely damaged lungs and serves as a temporary life support system, taking over heart function in cases of acute heart failure. This technology enables hospitals to stabilize patients and address underlying health issues effectively, while also allowing for increased patient mobility during treatment.

NavVis

Series B in 2015
NavVis develops indoor spatial intelligence solutions, enabling enterprises to capture and share built environments as photorealistic digital twins. Its SLAM-based mobile mapping systems generate high-quality data with survey-grade accuracy, facilitating better operational decisions and improved productivity.

Efficient Energy

Venture Round in 2015
Efficient Energy GmbH, based in Feldkirchen near Munich, Germany, specializes in the development, manufacturing, and distribution of environmentally friendly refrigeration systems for both industrial and home applications. Established in 2006, the company is recognized for its innovative eChiller, which utilizes pure water as a refrigerant, effectively avoiding the use of harmful fluorinated gases. This technology addresses regulatory challenges in refrigeration while providing efficient cooling solutions for data centers, server rooms, and various industrial processes. The eChiller models offer cooling capacities ranging from 35 kW to 120 kW and are designed to deliver cost efficiency and a low carbon footprint. Efficient Energy also provides a range of services, including consulting, planning, installation, and maintenance, ensuring optimal energy efficiency for its clients. The company's pioneering work has garnered multiple awards, highlighting its commitment to sustainable practices in refrigeration technology.

Siltectra

Series B in 2015
SILTECTRA GmbH, founded in 2010 and based in Dresden, Germany, specializes in advanced laser-based wafering technology for semiconductor manufacturers. The company has developed innovative kerfless wafering and thinning solutions that enable the separation of wafers from semiconductor materials, such as silicon carbide, gallium nitride, and sapphire, without material loss. This technology is particularly beneficial for applications in solar inverters and various electronic devices, providing significant performance and cost advantages to the global semiconductor industry. SILTECTRA operates as a subsidiary of Infineon Technologies AG and aims to enhance manufacturing processes across multiple industries through its cutting-edge solutions.

NavVis

Series A in 2014
NavVis develops indoor spatial intelligence solutions, enabling enterprises to capture and share built environments as photorealistic digital twins. Its SLAM-based mobile mapping systems generate high-quality data with survey-grade accuracy, facilitating better operational decisions and improved productivity.

Siltectra

Series A in 2014
SILTECTRA GmbH, founded in 2010 and based in Dresden, Germany, specializes in advanced laser-based wafering technology for semiconductor manufacturers. The company has developed innovative kerfless wafering and thinning solutions that enable the separation of wafers from semiconductor materials, such as silicon carbide, gallium nitride, and sapphire, without material loss. This technology is particularly beneficial for applications in solar inverters and various electronic devices, providing significant performance and cost advantages to the global semiconductor industry. SILTECTRA operates as a subsidiary of Infineon Technologies AG and aims to enhance manufacturing processes across multiple industries through its cutting-edge solutions.

Efficient Energy

Venture Round in 2013
Efficient Energy GmbH, based in Feldkirchen near Munich, Germany, specializes in the development, manufacturing, and distribution of environmentally friendly refrigeration systems for both industrial and home applications. Established in 2006, the company is recognized for its innovative eChiller, which utilizes pure water as a refrigerant, effectively avoiding the use of harmful fluorinated gases. This technology addresses regulatory challenges in refrigeration while providing efficient cooling solutions for data centers, server rooms, and various industrial processes. The eChiller models offer cooling capacities ranging from 35 kW to 120 kW and are designed to deliver cost efficiency and a low carbon footprint. Efficient Energy also provides a range of services, including consulting, planning, installation, and maintenance, ensuring optimal energy efficiency for its clients. The company's pioneering work has garnered multiple awards, highlighting its commitment to sustainable practices in refrigeration technology.

Siltectra

Series A in 2013
SILTECTRA GmbH, founded in 2010 and based in Dresden, Germany, specializes in advanced laser-based wafering technology for semiconductor manufacturers. The company has developed innovative kerfless wafering and thinning solutions that enable the separation of wafers from semiconductor materials, such as silicon carbide, gallium nitride, and sapphire, without material loss. This technology is particularly beneficial for applications in solar inverters and various electronic devices, providing significant performance and cost advantages to the global semiconductor industry. SILTECTRA operates as a subsidiary of Infineon Technologies AG and aims to enhance manufacturing processes across multiple industries through its cutting-edge solutions.

Siltectra

Seed Round in 2012
SILTECTRA GmbH, founded in 2010 and based in Dresden, Germany, specializes in advanced laser-based wafering technology for semiconductor manufacturers. The company has developed innovative kerfless wafering and thinning solutions that enable the separation of wafers from semiconductor materials, such as silicon carbide, gallium nitride, and sapphire, without material loss. This technology is particularly beneficial for applications in solar inverters and various electronic devices, providing significant performance and cost advantages to the global semiconductor industry. SILTECTRA operates as a subsidiary of Infineon Technologies AG and aims to enhance manufacturing processes across multiple industries through its cutting-edge solutions.

NFON

Venture Round in 2012
NFON is a Munich-based provider of cloud-based telecommunications services, specializing in integrated business communication solutions for corporate customers across Europe. The company's primary offering is its outsourced telephone system, known as IP Centrex, which delivers a comprehensive package designed to help businesses of all sizes reduce phone system costs by up to 50%. NFON's services encompass various aspects of business communication, including telephony, video calls, and screen sharing, along with necessary hardware components. The company also focuses on integration, ensuring that its cloud telephony system seamlessly fits into existing customer workflows and business processes. Additionally, NFON offers products aimed at optimizing customer contact, as well as services that prepare companies for cloud transition, enhancing their operational efficiency. With a fully redundant, high-performance computer center and over 100 functions, NFON is positioned as a key player in the telecommunications sector.

AFFiRiS

Venture Round in 2011
AFFiRiS AG is a biotechnology company based in Vienna, Austria, specializing in the development and manufacture of peptide-based vaccines aimed at the therapeutic treatment of chronic diseases with significant unmet medical needs. Founded in 2003, the company focuses on creating tailored vaccines for a range of conditions, including Alzheimer’s disease, Parkinson’s disease, atherosclerosis, hypertension, diabetes, psoriasis, allergies, asthma, and Huntington’s disease, among others. Through its innovative approach, AFFiRiS seeks to address critical health challenges and improve patient outcomes in various therapeutic areas.

IDENT Technology

Venture Round in 2011
IDENT Technology AG specializes in developing and licensing innovative technology solutions for near-field communication (NFC) and human-machine interface (HMI), focusing on capacitive near-field detection, interaction, and identification applications. Their flagship products include SKINPLEX GestIC for gesture detection, SKINPLEX zeropower sensor system for touchless sensing in harsh environments, and SKINPLEX ultra-low-power proximity system for device wake-up and power-down functionality. Established in 2002 and headquartered in Wessling, Germany, IDENT Technology serves a diverse range of industries such as consumer electronics, automotive, healthcare, and telecommunications.

AMSilk

Series B in 2011
AMSilk GmbH is a Munich-based company that specializes in the production of spider silk proteins and other biomaterials for a variety of industrial applications. Founded in 2008, AMSilk manufactures high-quality silk biopolymers that serve diverse sectors, including pharmaceuticals, cosmetics, and technical textiles. Its product offerings include BioShield-S1, a non-immunogenic spider silk film for protective coatings, as well as biosteel spider silk fibers. The company also develops a range of wound care products and surgical applications, such as the SanaSilk durable skin barrier. Additionally, AMSilk provides spider silk protein beads and coatings for medical technology, alongside nonwovens for filters, wound dressings, and specialty textiles. Utilizing a patented biotechnological process, AMSilk's materials are fully biodegradable under aerobic and marine conditions, promoting sustainability in various applications. The company collaborates with partners like Gruschwitz Textilwerke AG to enhance its product offerings.

Efficient Energy

Venture Round in 2011
Efficient Energy GmbH, based in Feldkirchen near Munich, Germany, specializes in the development, manufacturing, and distribution of environmentally friendly refrigeration systems for both industrial and home applications. Established in 2006, the company is recognized for its innovative eChiller, which utilizes pure water as a refrigerant, effectively avoiding the use of harmful fluorinated gases. This technology addresses regulatory challenges in refrigeration while providing efficient cooling solutions for data centers, server rooms, and various industrial processes. The eChiller models offer cooling capacities ranging from 35 kW to 120 kW and are designed to deliver cost efficiency and a low carbon footprint. Efficient Energy also provides a range of services, including consulting, planning, installation, and maintenance, ensuring optimal energy efficiency for its clients. The company's pioneering work has garnered multiple awards, highlighting its commitment to sustainable practices in refrigeration technology.

Corimmun

Series B in 2010
Corimmun is a clinical drug development company based in Martinsried, near Munich, Germany, specializing in innovative therapeutics and diagnostics for heart and vascular diseases. The company is dedicated to addressing unmet medical needs in the field of cardiovascular health. Corimmun's expertise encompasses the entire process of drug development, from initial research through to commercialization. By focusing on novel treatment options, Corimmun aims to improve outcomes for patients suffering from cardiovascular conditions.

IDENT Technology

Venture Round in 2010
IDENT Technology AG specializes in developing and licensing innovative technology solutions for near-field communication (NFC) and human-machine interface (HMI), focusing on capacitive near-field detection, interaction, and identification applications. Their flagship products include SKINPLEX GestIC for gesture detection, SKINPLEX zeropower sensor system for touchless sensing in harsh environments, and SKINPLEX ultra-low-power proximity system for device wake-up and power-down functionality. Established in 2002 and headquartered in Wessling, Germany, IDENT Technology serves a diverse range of industries such as consumer electronics, automotive, healthcare, and telecommunications.

Biocrates Life Sciences

Venture Round in 2010
Biocrates Life Sciences AG is a biotechnology company based in Innsbruck, Austria, specializing in targeted metabolic phenotyping solutions. Founded in 2002, the company develops and markets mass-spectrometry based kits and services that facilitate the analysis of endogenous metabolites. These tools are essential for discovering and validating biomarkers associated with complex multifactorial diseases, including cancer and neurodegenerative disorders. Biocrates provides a comprehensive metabolomics platform that integrates automated sample preparation workflows with advanced mass-spectrometric techniques, enabling rapid and reliable identification of hundreds of metabolites. Their products and services cater to a wide range of research areas, such as cardiovascular health, diabetes, endocrinology, pharmacology, and more. Biocrates Life Sciences distributes its solutions through authorized partners across various regions, including the Middle East, Europe, and parts of Asia.

PDC Biotech

Series A in 2010
PDC Biotech GmbH is a biotechnology company based in Vienna, Austria, specializing in the development of innovative therapeutics for the treatment of preterm labor and primary dysmenorrhea, addressing significant unmet medical needs. Founded in 2008, the company focuses on a pipeline of products that target the prostaglandin F2α (FP) receptor, including synthetic octapeptides designed as allosteric modulators of this receptor. Key products in development include PDC31 and the PDC41 Series, a non-intravenous formulation intended for self-administration by patients. PDC Biotech employs various delivery methods for its formulations, such as nasal, sublingual, pulmonary, vaginal, and rectal suppositories. The company has secured exclusive worldwide rights to a family of FP receptor antagonists, enabling it to advance its therapeutic offerings in the biopharmaceutical sector.

Efficient Energy

Seed Round in 2008
Efficient Energy GmbH, based in Feldkirchen near Munich, Germany, specializes in the development, manufacturing, and distribution of environmentally friendly refrigeration systems for both industrial and home applications. Established in 2006, the company is recognized for its innovative eChiller, which utilizes pure water as a refrigerant, effectively avoiding the use of harmful fluorinated gases. This technology addresses regulatory challenges in refrigeration while providing efficient cooling solutions for data centers, server rooms, and various industrial processes. The eChiller models offer cooling capacities ranging from 35 kW to 120 kW and are designed to deliver cost efficiency and a low carbon footprint. Efficient Energy also provides a range of services, including consulting, planning, installation, and maintenance, ensuring optimal energy efficiency for its clients. The company's pioneering work has garnered multiple awards, highlighting its commitment to sustainable practices in refrigeration technology.

Corimmun

Series A in 2008
Corimmun is a clinical drug development company based in Martinsried, near Munich, Germany, specializing in innovative therapeutics and diagnostics for heart and vascular diseases. The company is dedicated to addressing unmet medical needs in the field of cardiovascular health. Corimmun's expertise encompasses the entire process of drug development, from initial research through to commercialization. By focusing on novel treatment options, Corimmun aims to improve outcomes for patients suffering from cardiovascular conditions.

Biocrates Life Sciences

Series A in 2006
Biocrates Life Sciences AG is a biotechnology company based in Innsbruck, Austria, specializing in targeted metabolic phenotyping solutions. Founded in 2002, the company develops and markets mass-spectrometry based kits and services that facilitate the analysis of endogenous metabolites. These tools are essential for discovering and validating biomarkers associated with complex multifactorial diseases, including cancer and neurodegenerative disorders. Biocrates provides a comprehensive metabolomics platform that integrates automated sample preparation workflows with advanced mass-spectrometric techniques, enabling rapid and reliable identification of hundreds of metabolites. Their products and services cater to a wide range of research areas, such as cardiovascular health, diabetes, endocrinology, pharmacology, and more. Biocrates Life Sciences distributes its solutions through authorized partners across various regions, including the Middle East, Europe, and parts of Asia.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.